Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair

기사 요약

Axogen is acquiring BioCircuit Technologies for $200 million to add sutureless NerveTape to its portfolio, funded by a public stock offering.